{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:01:52Z","timestamp":1763535712062,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2020.00155","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T05:57:02Z","timestamp":1588658222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Serious Hemorrhagic Complications After Successful Treatment of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy With Defibrotide in Pediatric Patient With Myelodysplastic Syndrome"],"prefix":"10.3389","volume":"8","author":[{"given":"Alexandra","family":"Laberko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Aksenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Shipitsina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Khamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Shcherbina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Balashov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","article-title":"The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Cooke","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ajh.20648","article-title":"Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Nakamae","year":"2006","journal-title":"Am J Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/bmt.2015.161","article-title":"The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"50","author":"Balassa","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood."},{"key":"B6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","article-title":"Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis","volume":"19","author":"Shayani","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1038\/mtna.2016.42","article-title":"Defibrotide (Defitelio): A new addition to the stockpile of food and drug administration-approved oligonucleotide drugs","volume":"5","author":"Stein","year":"2016","journal-title":"Mol Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41409-018-0256-8","article-title":"Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy","volume":"54","author":"Mart\u00ednez-Mu\u00f1oz","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/bmt.2016.351","article-title":"Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation","volume":"52","author":"Yeates","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B12","first-page":"585","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","volume-title":"World Health Organization Classification of Tumours","author":"Swerdlow","year":"2017"},{"key":"B13","first-page":"1","article-title":"Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","author":"KDIGO","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fped.2019.00133","article-title":"Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management","volume":"7","author":"Dvorak","year":"2019","journal-title":"Front Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/bmt.2017.207","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies","volume":"53","author":"Khosla","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.bbmt.2013.07.001","article-title":"Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide","volume":"19","author":"Carmona","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1309\/AJCP7W9VMJENZOVG","article-title":"Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics","volume":"133","author":"Cioc","year":"2010","journal-title":"Am J Clin Pathol."},{"key":"B19","unstructured":"FlanaganM\n          Bloom Syndrome"},{"key":"B20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13023-019-1073-x","article-title":"Hematopoietic stem cell transplantation in a patient with type 1 mosaic variegated aneuploidy syndrome","volume":"14","author":"Laberko","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.bbmt.2017.08.019","article-title":"Thrombotic microangiopathy after allogeneic stem cell transplantation: a comparison of eculizumab therapy and conventional therapy","volume":"23","author":"Bohl","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.bbmt.2016.07.001","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the international compassionate-use program","volume":"22","author":"Corbacioglu","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1160\/TH17-04-0275","article-title":"Defibrotide stimulates angiogenesis and protects endothelial cells from calcineurin inhibitor-induced apoptosis via upregulation of AKT\/Bcl-xL","volume":"118","author":"Wang","year":"2018","journal-title":"Thromb Haemost."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1182\/blood-2015-10-676114","article-title":"What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance","volume":"127","author":"Palomo","year":"2016","journal-title":"Blood."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/sj.leu.2403004","article-title":"Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells","volume":"17","author":"Falanga","year":"2003","journal-title":"Leukemia."},{"key":"B27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/MBC.0b013e32832da1e3","article-title":"The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity","volume":"20","author":"Echart","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bjh.15267","article-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"181","author":"Kernan","year":"2018","journal-title":"Br J Haematol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.bbmt.2018.02.015","article-title":"Defibrotide for sinusoidal obstruction syndrome\/veno-occlusive disease prophylaxis in high-risk adult patients: a single-center experience study","volume":"24","author":"Picod","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.bbmt.2012.12.012","article-title":"Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell transplantation","volume":"19","author":"Rajpal","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/bmt.2012.85","article-title":"The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT","volume":"48","author":"Shimoi","year":"2012","journal-title":"Bone Marrow Transplant."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2020.00155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T05:57:06Z","timestamp":1588658226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2020.00155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":31,"alternative-id":["10.3389\/fped.2020.00155"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.00155","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"article-number":"155"}}